RT info:eu-repo/semantics/article
T1 Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
A1 Calleja, José L.
A1 Rivera‐Esteban, Jesús
A1 Aller de la Fuente, Rocío
A1 Hernández‐Conde, Marta
A1 Abad, Javier
A1 Pericàs, Juan M.
A1 Benito, Hugo G.
A1 Serra, Miguel A.
A1 Escudero, Amparo
A1 Ampuero, Javier
A1 Lucena, Ana
A1 Sánchez, Yolanda
A1 Arias‐Loste, María T.
A1 Iruzubieta, Paula
A1 Romero‐Gómez, Manuel
A1 Augustin, Salvador
A1 Crespo, Javier
AB Background & Aims: Non-alcoholic fatty liver disease (NAFLD) has become a majorpublic health problem, but the prevalence of fibrosis associated with non-alcoholicsteatohepatitis (NASH) is largely unknown in the general population. This study aimedto provide an updated estimation of the prevalence of NASH fibrosis in Spain.Methods: This was an observational, retrospective, cross-sectional, population-basedstudy with merged data from two Spanish datasets: a large (N = 12 246) populationbased cohort (ETHON), including transient elastography (TE) data, and a contemporary multi-centric biopsy-proven NASH cohort with paired TE data from tertiarycentres (N = 501). Prevalence for each NASH fibrosis stage was estimated by crossingTE data from ETHON dataset with histology data from the biopsy-proven cohort.
SN 1478-3223
YR 2022
FD 2022
LK https://uvadoc.uva.es/handle/10324/64574
UL https://uvadoc.uva.es/handle/10324/64574
LA spa
NO . Liver Int. 2022 Aug;42(8):1783-1792
DS UVaDOC
RD 15-jun-2024